Ozempic now indicated to prevent CKD progression
Ozempic is the first medicine in Australia approved to slow kidney disease progression in patients with both type 2 diabetes and CKD.
Paediatric risperidone errors prompt TGA safety update
The TGA has tightened dosing advice for the antipsychotic risperidone after an alarming number of overdoses occurred in patients under 18.
Aspiration precautions for diabetes and weight-management therapies
Following several incident reports, the Therapeutic Goods Administration issued new precautions linked to these popular therapies.
A new way to discuss inhaler technique
By distinguishing between the two different types of inspiratory flow rates, this new label could help to improve inhaler technique.
Dealing with aggressive customers? You’re not alone
As confirmed cases of COVID-19 in Australia tick over 4,700, many pharmacists face long working hours and the rising challenge of unacceptable customer behaviour.
Valvular heart disease: how pharmacists can help
More than 250,000 Australians have faulty heart valves and are at risk of serious complications, including heart failure, stroke and death – yet don’t know it. Australian Pharmacist spoke to an expert about the symptoms pharmacists should be aware of.
